|
Market Closed -
Nasdaq
16:00:00 2026-09-01 EDT
|
5-day change | 1st Jan Change | ||
| 82.74 USD | +0.42% |
|
-6.91% | +24.63% |
| Market Cap | 11.69B 10.08B 9.48B 8.64B 16.25B 1,109B 16.33B 112B 43.64B 564B 43.88B 42.93B 1,871B | P/E 2026 * |
-22.7x | P/E 2027 * | -17.9x |
|---|---|---|---|---|---|
| Enterprise Value | 10.86B 9.36B 8.81B 8.02B 15.09B 1,030B 15.17B 104B 40.53B 524B 40.76B 39.87B 1,738B | EV / Sales 2026 * |
23.5x | EV / Sales 2027 * | 31.8x |
| Free-Float |
94.56% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript : Arrowhead Pharmaceuticals, Inc.
| 1 day | +0.42% | ||
| 1 week | -6.91% | ||
| Current month | +0.42% | ||
| 1 month | -2.26% | ||
| 3 months | +10.03% | ||
| 6 months | +30.77% | ||
| Current year | +24.63% |
| 1 week | 80.75 |  | 89.59 |
| 1 month | 80.75 | | 90.97 |
| Current year | 54.02 | | 95.49 |
| 1 year | 25.61 | | 95.49 |
| 3 years | 9.57 | | 95.49 |
| 5 years | 9.57 | | 95.49 |
| 10 years | 1.2 | | 95.49 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 56 | 2007-11-30 | |
Daniel Apel
DFI | Director of Finance/CFO | - | 2025-05-12 |
Peter Carignan
CTO | Chief Tech/Sci/R&D Officer | - | 2022-07-31 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 56 | - | |
Mauro Ferrari
BRD | Director/Board Member | 66 | 2010-08-18 |
Michael Perry
BRD | Director/Board Member | 66 | 2011-12-18 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 8/18/26 | Sell | Director | -2,000 | 0.0014% | ||
| 8/18/26 | Sell | Director | -11,600 | 0.0082% | ||
| 6/15/26 | Free | Director | 11,882 | 0.0084% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.42% | -6.91% | +275.58% | +195.92% | 11.69B | |
| -0.25% | -4.10% | +38.38% | +92.61% | 68.21B | |
| +2.19% | +0.89% | +49.44% | +90.69% | 64.25B | |
| -0.25% | -1.92% | -10.72% | +436.70% | 26.54B | |
| +0.33% | -10.61% | +1.95% | -16.27% | 25.61B | |
| +2.14% | +1.44% | +32.57% | -17.76% | 19.88B | |
| -6.09% | -12.08% | +226.11% | +375.00% | 17.13B | |
| +0.65% | -5.28% | -1.12% | +534.90% | 14.93B | |
| +4.12% | +0.30% | +52.03% | +150.18% | 14.1B | |
| -0.24% | +5.18% | +23.04% | +190.97% | 12.45B | |
| Average | +0.30% | -4.22% | +68.72% | +203.30% | 27.48B | |
| Weighted average by Cap. | +0.49% | -3.38% | +52.06% | +160.70% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 461M 398M 374M 341M 641M 43.76B 644M 4.42B 1.72B 22.26B 1.73B 1.69B 73.81B | 346M 299M 281M 256M 481M 32.85B 484M 3.32B 1.29B 16.71B 1.3B 1.27B 55.41B |
| Net income | -518M -447M -421M -383M -721M -49.21B -725M -4.97B -1.94B -25.03B -1.95B -1.9B -83B | -650M -560M -527M -480M -903M -61.64B -908M -6.23B -2.43B -31.36B -2.44B -2.39B -104B |
| Net Debt | -832M -718M -675M -615M -1.16B -79B -1.16B -7.98B -3.11B -40.18B -3.13B -3.06B -133B | -683M -589M -554M -505M -949M -64.8B -954M -6.55B -2.55B -32.96B -2.56B -2.51B -109B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-09-01 | US$82.74 | +0.42% | 1,330,720 |
| 26-08-31 | US$82.39 | -2.97% | 1,595,518 |
| 26-08-28 | US$84.91 | -4.15% | 1,282,278 |
| 26-08-27 | US$88.59 | -0.59% | 857,522 |
| 26-08-26 | US$89.12 | +0.27% | 859,486 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- ARWR Stock
Select your edition
All financial news and data tailored to specific country editions
